Month: June 2021

Table 1: Lagoa Salgada Resources (North and South Zones)Table 1: Lagoa Salgada Resources (North and South Zones)New 43-101 Resource followed by results from PFS level metallurgical testing expected to be issued in the near term New PEA expected by end of July 2021, to show increased scale and economic potential versus PEA published in December 2019TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — Ascendant Resources Inc. (TSX: ASND) (FRA: 2D9) (“Ascendant” or the “Company”) is pleased to announce that it has engaged to undertake the new NI 43-101 Preliminary Economic Assessment (“PEA”) for its Lagoa Salgada VMS project in Portugal. Both Quadrante and IGAN have extensive experience on the Iberian Pyrite Belt, The PEA will be designed to look at a combined mining operation encompassing the mineralization...

ATLANTA, June 09, 2021 (GLOBE NEWSWIRE) — UPS (NYSE:UPS) will host its investor and analyst conference today beginning at 9:00 a.m. EDT. The virtual event will be available in its entirety through a live webcast and replay at investors.ups.com. The company will highlight priorities for its Customer First, People Led, Innovation Driven strategy; discuss targeted areas of growth including small and medium-sized businesses, healthcare and international; provide 2023 financial targets; and discuss newly established ESG targets.Customer First:  The company’s Customer First strategy strives to provide the best digital experience powered by its global smart logistics network. The company will showcase the actions it is taking to make it simpler and more helpful to do business with UPS. Customer First focuses on removing friction when...

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH The Board of Sinch AB (publ) today announces a change to the company’s financial leverage policy. The new policy is as follows:Sinch’s target is that net debt over time shall be below 3.5 times adjusted EBITDA (measured on a rolling twelve month basis).The phrase ‘over time’ means that leverage may temporarily exceed the targeted level in the near term following an acquisition. Before today’s announcement, the policy was that net debt over time shall be below 2.5 times adjusted EBITDA (measured on a rolling twelve month basis). Sinch’s other financial targets remain unchanged:Growth in adjusted EBITDA per share shall be 20 per cent per year. Dividend policy: The Board continues to see good growth opportunities through acquisitions over the next few years, and therefore proposes that...

– Poster title: A novel drug response predictor (DRP®) mRNA biomarker for the multi tyrosine kinase inhibitor dovitinib – Poster provides new details of the DRP® companion diagnostic for dovitinib, its lead oncology pipeline asset Press release Hørsholm, Denmark (9 June 2021) Allarity Therapeutics A/S (“Allarity” or the “Company”) today announces the publication of an e-Poster titled ‘A novel drug response predictor (DRP®) mRNA biomarker for the multi tyrosine kinase inhibitor dovitinib’ at the European Association for Cancer Research (EACR) 2021 Virtual Congress held from 9 – 12 June 2021. The e-Poster is also available on the Company’s website on: https://allarity.com/technology/scientific-publications The e-Poster describes Allarity’s latest research into the Company’s novel companion diagnostic for dovitinib, known as the Dovitinib-DRP®...

InformationJune 9, 2021Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers Information relating to the total number of shares and voting rights comprising the share capital as of 31 May 2021Date Total number of shares1 comprising the share capital Theoretical number of voting rights231/05/2021 186 981 576 186 981 576* * * Contact details CommunicationsJérôme Guilbert+33 (0)1 58 44 79 19jguilbert@scor.com Investor RelationsOlivier Armengaud+33 (0)1 58 44 86 12oarmengaud@scor.com www.scor.com LinkedIn: SCOR        | Twitter: @SCOR_SE SCOR, a Global Tier 1 Reinsurer SCOR, the world’s fourth largest reinsurer, offers its clients a diversified and innovative range of solutions and services to control and manage risk. Applying...

ORION CORPORATION PRESS RELEASE 9 JUNE 2021 at 12.00 noon EEST          Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy A novel treatment, a digital therapeutics software solution for Chronic Pain (DTxP), has shown statistically significant benefit over passive (placebo) control and standard care interventions for fear of movement, patient clinical global impression of change (PGIC) and quality of life in adult patients with chronic low back pain (CLBP). Results from Orion Corporation’s pilot study ‘VIRPI’ were announced at the IASP 2021 Virtual World Congress On Pain. Results from the ‘VIRPI’ study in patients with CLBP showed that TSK score (Tampa Scale for Kinesiophobia assessing fear of movement) was significantly reduced at the end-of-intervention (EOI) for DTxP. Primary...

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18262 DKT 01/09/21 III 1,260 1,000 -0.522 100 % 100.119098 18346 DKT 01/12/21 IV 760 560 -0.520 100 % 100.250598 18429 DKT 01/03/22 I 1,700 1,600 -0.520 100 % 100.381398 18502 DKT 01/06/22 II 740 640 -0.520 100 % 100.5154Total 4,460 3,800      The sale will settle 11 June 2021